J Albanèse Selected Research

hydroxyethylstarch 200

4/2008

Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Albanèse Research Topics

Disease

4	Septic Shock (Toxic Shock Syndrome) 09/2014 - 07/2003
2	Critical Illness (Critically Ill) 02/2018 - 05/2014
2	Infections 09/2014 - 04/2003
2	Wounds and Injuries (Trauma) 09/2008 - 07/2008
2	Hypoxia (Hypoxemia) 03/2008 - 01/2008
2	Sepsis (Septicemia) 01/2008 - 11/2003
2	Intracranial Hypertension 08/2006 - 05/2004
2	Heart Arrest (Cardiac Arrest) 03/2001 - 06/2000
1	Hemolysis 09/2014
1	Myotonic Dystrophy (Dystrophia Myotonica) 02/2012
1	Heart Injuries 09/2008
1	Hemorrhage 09/2008
1	Rupture 09/2008
1	Acute Lung Injury 07/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2008
1	Brain Death (Brain Dead) 04/2008
1	Delayed Graft Function 04/2008
1	Healthcare-Associated Pneumonia 07/2006
1	Pneumonia (Pneumonitis) 07/2006
1	Chronic Disease (Chronic Diseases) 07/2004
1	Anemia 07/2004
1	Craniocerebral Trauma (Head Injury) 05/2004
1	Mycoses (Diseases, Fungus) 11/2003
1	Shock 07/2003
1	Hypotension (Low Blood Pressure) 07/2003
1	Surgical Wound Infection 04/2003
1	Body Weight (Weight, Body) 05/2000
1	Meningitis 05/2000

Drug/Important Bio-Agent (IBA)

2	CreatinineIBA 05/2014 - 04/2008
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2003 - 03/2001
1	Clostridium perfringens theta-toxinIBA 09/2014
1	Rocuronium (Zemuron)FDA LinkGeneric 02/2012
1	SugammadexIBA 02/2012
1	Factor VIIa (Activated Factor VII)IBA 09/2008
1	recombinant FVIIa (rFVIIa)FDA Link 09/2008
1	hydroxyethylstarch 200IBA 04/2008
1	HES 130-0.4IBA 04/2008
1	Oxygen (Dioxygen)IBA 01/2008
1	Neuromuscular Blocking AgentsIBA 08/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2006
1	Erythropoietin FDA Link 07/2004
1	CurareIBA 05/2004
1	Fluconazole (Zonal)FDA LinkGeneric 11/2003
1	Antifungal AgentsIBA 11/2003
1	Protein CIBA 11/2003
1	SteroidsIBA 11/2003
1	CatecholaminesIBA 07/2003
1	Vasopressins (Vasopressin)IBA 07/2003
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2003
1	sulprostoneIBA 03/2001
1	Chloroquine (Aralen)FDA LinkGeneric 06/2000
1	Vancomycin FDA LinkGeneric 05/2000

Therapy/Procedure

3	Therapeutics 09/2008 - 06/2000
2	Resuscitation 02/2018 - 04/2008
2	Mechanical Ventilators (Ventilator) 07/2008 - 07/2006
2	Artificial Respiration (Mechanical Ventilation) 07/2008 - 03/2008
2	Critical Care (Surgical Intensive Care) 07/2008 - 07/2006
1	Blood Transfusion (Blood Transfusions) 09/2008
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 09/2008
1	Transplantation 04/2008
1	Perioperative Period 01/2008
1	Analgesia 05/2004
1	Nephrectomy 04/2003